Amedisys, Inc. (AMED)
Aug 14, 2025 - AMED was delisted (reason: acquired by UNH)
100.99
+0.01 (0.01%)
Inactive · Last trade price on Aug 14, 2025
Amedisys Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 85.63 | 43.23 | -9.75 | 118.61 | 209.07 | 183.61 |
Depreciation & Amortization | 61.75 | 60.46 | 57.64 | 68.86 | 71.27 | 67.94 |
Other Amortization | 0.94 | 0.99 | 0.99 | 0.99 | 0.92 | 0.87 |
Loss (Gain) From Sale of Assets | -1.68 | -1.65 | 2.51 | 0.52 | -0.12 | -0.03 |
Asset Writedown & Restructuring Costs | 49.27 | 48.39 | 0.2 | 5.11 | - | 4.15 |
Loss (Gain) From Sale of Investments | -51.66 | - | - | - | -31.1 | 2.98 |
Loss (Gain) on Equity Investments | -0.99 | -2.64 | -5.69 | 5.21 | 0.39 | 1.48 |
Stock-Based Compensation | 29.2 | 30.64 | 29.02 | 16.56 | 23.81 | 26.73 |
Other Operating Activities | 13.48 | 2.35 | 125.47 | 22.47 | 45.68 | -25 |
Change in Accounts Receivable | 61.39 | 16.48 | -26.73 | -14.23 | -18.03 | 2.11 |
Change in Accounts Payable | 4.1 | 12.21 | -15.82 | 4.89 | -4.35 | 1.94 |
Change in Other Net Operating Assets | -12 | 11.21 | -20.66 | -95.71 | -108.64 | 22.17 |
Operating Cash Flow | 239.43 | 221.67 | 137.19 | 133.28 | 188.89 | 288.95 |
Operating Cash Flow Growth | 148.80% | 61.58% | 2.93% | -29.44% | -34.63% | 43.05% |
Capital Expenditures | -4.41 | -6.55 | -5.62 | -6.17 | -6.3 | -5.33 |
Sale of Property, Plant & Equipment | 0.02 | - | 0.14 | 0.07 | 0.14 | 0.08 |
Cash Acquisitions | - | - | -0.35 | -71.95 | -269.97 | -298.96 |
Divestitures | - | - | 47.79 | - | - | - |
Sale (Purchase) of Intangibles | -0.84 | -0.82 | -7.09 | -1.05 | -0.42 | - |
Investment in Securities | -0.85 | -1.05 | 0.15 | -15.64 | -5.2 | 17 |
Other Investing Activities | 0.06 | 0.06 | 0.05 | 0.25 | 0.14 | 0.1 |
Investing Cash Flow | -6.02 | -8.36 | 35.06 | -94.49 | -281.61 | -287.11 |
Short-Term Debt Issued | - | - | 23 | 534.5 | - | - |
Long-Term Debt Issued | - | - | - | - | 791.01 | 684.2 |
Total Debt Issued | - | - | 23 | 534.5 | 791.01 | 684.2 |
Short-Term Debt Repaid | - | - | -23 | -534.5 | - | - |
Long-Term Debt Repaid | - | -37.36 | -76.01 | -13.3 | -560.84 | -713.45 |
Total Debt Repaid | -38.53 | -37.36 | -99.01 | -547.8 | -560.84 | -713.45 |
Net Debt Issued (Repaid) | -38.53 | -37.36 | -76.01 | -13.3 | 230.17 | -29.25 |
Issuance of Common Stock | 0.46 | 0.31 | 2.7 | 6.15 | 6.02 | 9.89 |
Repurchase of Common Stock | -7.96 | -6.15 | -6.53 | -25.33 | -116.78 | -54.49 |
Other Financing Activities | -7.43 | -5.72 | -7.68 | 2.04 | -64.29 | 58.88 |
Financing Cash Flow | -53.46 | -48.92 | -87.52 | -30.43 | 55.13 | -14.98 |
Net Cash Flow | 179.95 | 164.38 | 84.73 | 8.36 | -37.59 | -13.13 |
Free Cash Flow | 235.02 | 215.12 | 131.57 | 127.12 | 182.59 | 283.62 |
Free Cash Flow Growth | 163.17% | 63.50% | 3.50% | -30.38% | -35.62% | 46.11% |
Free Cash Flow Margin | 9.78% | 9.16% | 5.88% | 5.72% | 8.25% | 13.69% |
Free Cash Flow Per Share | 7.08 | 6.51 | 4.04 | 3.89 | 5.54 | 8.53 |
Cash Interest Paid | 26.84 | 29.99 | 29.77 | 27.69 | 5.29 | 6.21 |
Cash Income Tax Paid | 47.03 | 40.1 | 29.13 | 24.01 | 34.1 | 50.72 |
Levered Free Cash Flow | 300.69 | 277.51 | 258.61 | 122.2 | 112.9 | 368.1 |
Unlevered Free Cash Flow | 317 | 295.74 | 277.17 | 135.1 | 117.93 | 374.13 |
Change in Working Capital | 53.49 | 39.9 | -63.21 | -105.04 | -131.02 | 26.22 |
Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.